Niagen Bioscience, Inc. (NAGE) Net margin 2017–2025
Niagen Bioscience, Inc. (NAGE) net profit margin by fiscal year — reported net income divided by reported revenue.
13.4%FY2025 · since FY2017: -53.7% → 13.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 13.4% | +4.8 pp |
| FY2024 | 8.6% | +14.5 pp |
| FY2023 | -5.9% | +17.0 pp |
| FY2022 | -23.0% | +17.3 pp |
| FY2021 | -40.2% | -6.6 pp |
| FY2020 | -33.6% | +35.8 pp |
| FY2019 | -69.4% | +36.1 pp |
| FY2018 | -105.6% | -51.9 pp |
| FY2017 | -53.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice